The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Pharmacological characterization of a novel cell line expressing human α4β3δ GABAA receptors
Open accessAbstract
The pharmacology of the stable cell line expressing human α 4 β 3 δ GABA A receptor was investigated using whole‐cell patch‐clamp techniques. α 4 β 3 δ receptors exhibited increased sensitivity to GABA when compared to α 4 β 3 γ 2 receptors, with EC 50's of 0.50 (0.46, 0.53) μ M and 2.6 (2.5, 2.6) μ M respectively. Additionally, the GABA partial agonists piperidine‐4‐sulphonate (P4S) and 4,5,6,7‐tetrahydroisothiazolo‐[5,4‐c]pyridin‐3‐ol (THIP) displayed markedly higher efficacy at α 4 β 3 δ receptors, indeed THIP demonstrated greater efficacy than GABA at these receptors. The δ subunit conferred slow desensitization to GABA, with rate constants of 4.8±0.5 s for α 4 β 3 δ and 2.5±0.2 s for α 4 β 3 γ 2. However, both P4S and THIP demonstrated similar levels of desensitization on both receptor subtypes suggesting this effect is agonist specific. α 4 β 3 δ and α 4 β 3 γ 2 demonstrated equal sensitivity to inhibition by the cation zinc (2–3 μ M IC 50). However, α 4 β 3 δ receptors demonstrated greater sensitivity to inhibition by lanthanum. The IC 50 for GABA antagonists SR‐95531 and picrotoxin, was similar for α 4 β 3 δ and α 4 β 3 γ 2. Likewise, inhibition was observed on both subtypes at high and low pH. α 4 β 3 δ receptors were insensitive to modulation by benzodiazepine ligands. In contrast Ro15‐4513 and bretazenil potentiated GABA responses on α 4 β 3 γ 2 cells, and the inverse agonist DMCM showed allosteric inhibition of α 4 β 3 γ 2 receptors. The efficacy of neurosteroids at α 4 β 3 δ receptors was greatly enhanced over that observed at α 4 β 3 γ 2 receptors. The greatest effect was observed using THDOC with 524±71.6% potentiation at α 4 β 3 δ and 297.9±49.7% at α 4 β 3 γ 2 receptors. Inhibition by the steroid pregnenolone sulphate however, showed no subtype selectivity. The efficacy of both pentobarbitone and propofol was slightly augmented and etomidate greatly enhanced at α 4 β 3 δ receptors versus α 4 β 3 γ 2 receptors. We show that the α 4 β 3 δ receptor has a distinct pharmacology and kinetic profile. With its restricted distribution within the brain and unique pharmacology this receptor may play an important role in the action of neurosteroids and anaesthetics. British Journal of Pharmacology (2002) 136, 965–974. doi:10.1038/sj.bjp.0704795
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GABAA receptors: immunocytochemical distribution of 13 subunits in the adult rat brain
Pirker, S., Schwarzer, C., Wieselthaler, A., Sieghart, W., & Sperk, G. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00442-5 · Cited by 1,344
Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes.
Sieghart, W. (1995) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06840-1 · Cited by 1,301
Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology
Pritchett, D. B., Sontheimer, H., Shivers, B. D., Ymer, S., Kettenmann, H., Schofield, P. R., & Seeburg, P. H. (1989) · Nature · doi:10.1038/338582a0 · Cited by 1,293
Which GABAA-receptor subtypes really occur in the brain?
McKernan, R. M., & Whiting, P. J. (1996) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)80023-3 · Cited by 1,222
Self-citationBarnard, E. A., Skolnick, P., Olsen, R. W., Möhler, H., Sieghart, W., Biggio, G., Bræstrup, C., Bateson, A. N., & Langer, S. Z. (1998) · PubMed · Cited by 1,204
Nusser, Z., Sieghart, W., & Somogyi, P. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-05-01693.1998 · Cited by 833
Brickley, S. G., Cull-Candy, S. G., & Farrant, M. (1996) · The Journal of Physiology · doi:10.1113/jphysiol.1996.sp021806 · Cited by 717
GABAA receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid
Smith, S. S., Gong, Q. H., Hsu, F.-C., Markowitz, R. S., ffrench-Mullen, J. M. H., & Li, X. (1998) · Nature · doi:10.1038/31948 · Cited by 564
Mihalek, R. M., Banerjee, P. K., Korpi, E. R., Quinlan, J. J., Firestone, L. L., Mi, Z.-P., Lagenaur, C., Tretter, V., Sieghart, W., Anagnostaras, S. G., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12905 · Cited by 520
Modulation of the GABA receptor complex by a steroid anaesthetic
Harrison, N. L., & Simmonds, M. A. (1984) · Brain Research · doi:10.1016/0006-8993(84)90299-3 · Cited by 499
A single histidine in GABAA receptors is essential for benzodiazepine agonist binding.
Wieland, H. A., Lüddens, H., & Seeburg, P. H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45961-3 · Cited by 447
Belelli, D., Lambert, J. J., Peters, J. A., Wafford, K., & Whiting, P. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.11031 · Cited by 392
Self-citationFunctional and molecular distinction between recombinant rat GABAA receptor subtypes by Zn2+
Draguhn, A., Verdorn, T. A., Ewert, M., Seeburg, P. H., & Sakmann, B. (1990) · Neuron · doi:10.1016/0896-6273(90)90337-f · Cited by 376
Assembly of GABAA receptor subunits: role of the delta subunit
Saxena, N., & Macdonald, R. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-11-07077.1994 · Cited by 338
GABAA receptor subunits in the rat hippocampus I: Immunocytochemical distribution of 13 subunits
Sperk, G., Schwarzer, C., Tsunashima, K., Fuchs, K., & Sieghart, W. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00146-2 · Cited by 335
Serra, M., Pisu, M. G., Littera, M., Papi, G., Sanna, E., Tuveri, F., Usala, L., Purdy, R. H., & Biggio, G. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750732.x · Cited by 315
θ, a novel γ-aminobutyric acid type A receptor subunit
Bonnert, T. P., McKernan, R. M., Farrar, S., le Bourdellès, B., Heavens, R. P., Smith, D. W., Hewson, L., Rigby, M. R., Sirinathsinghji, D. J. S., Brown, N., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9891 · Cited by 303
Self-citationProperties of putative cerebellar gamma-aminobutyric acid A receptor isoforms.
Saxena, N. C., & Macdonald, R. L. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08745-0 · Cited by 292
Neurosteroid pregnenolone sulfate antagonizes electrophysiological responses to GABA in neurons
Majewska, M. D., Mienville, J.-M., & Vicini, S. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90202-9 · Cited by 270
Wafford, K. A., Thompson, S. A., Thomas, D., Sikela, J., Wilcox, A. S., & Whiting, P. J. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09339-3 · Cited by 268
Self-citationWall, M. J., & Usowicz, M. M. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01630.x · Cited by 268
Haas, K. F., & Macdonald, R. L. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.027af.x · Cited by 267
Cloning, pharmacological characteristics and expression pattern of the rat GABAA receptor α4 subunit
Wisden, W., Herb, A., Wieland, H., Keinänen, K., Lüddens, H., & Seeburg, P. H. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)81076-k · Cited by 260
Modulation of the GABAA receptor by progesterone metabolites
Callachan, H., Cottrell, G. A., Hather, N. Y., Lambert, J. J., Nooney, J. M., & Peters, J. A. (1987) · Proceedings of the Royal Society of London. Series B. Biological Sciences · doi:10.1098/rspb.1987.0049 · Cited by 252
A Point Mutation in the Glutamate Binding Site Blocks Desensitization of AMPA Receptors
Stern-Bach, Y., Russo, S., Neuman, M., & Rosenmund, C. (1998) · Neuron · doi:10.1016/s0896-6273(00)80605-4 · Cited by 242
Preferential Coassembly of α4 and δ Subunits of the γ-Aminobutyric AcidAReceptor in Rat Thalamus
Sur, C., Farrar, S. J., Kerby, J., Whiting, P. J., Atack, J. R., & McKernan, R. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.110 · Cited by 228
Self-citationWhiting, P. J., McAllister, G., Vassilatis, D., Bonnert, T. P., Heavens, R. P., Smith, D. W., Hewson, L., O’Donnell, R., Rigby, M. R., Sirinathsinghji, D. J. S., et al. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-13-05027.1997 · Cited by 211
Self-citationKnoflach, F., Benke, D., Wang, Y., Scheurer, L., Lüddens, H., Hamilton, B. J., Carter, D. B., Mohler, H., & Benson, J. A. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09554-9 · Cited by 174
δ Subunit Inhibits Neurosteroid Modulation of GABAAReceptors
Zhu, W. J., Wang, J. F., Krueger, K. E., & Vicini, S. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-21-06648.1996 · Cited by 152
Coulter, D. A. (2001) · International review of neurobiology · doi:10.1016/s0074-7742(01)45013-6 · Cited by 150
The estrus cycle, sensitivity to convulsants and the anticonvulsant effect of a neuroactive steroid.
Finn, D. A., & Gee, K. W. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22739-2 · Cited by 147
Fisher, J. L., & Macdonald, R. L. (1997) · The Journal of Physiology · doi:10.1111/j.1469-7793.1997.283bb.x · Cited by 135
Proton sensitivity of the GABA(A) receptor is associated with the receptor subunit composition.
Krishek, B. J., Amato, A., Connolly, C. N., Moss, S. J., & Smart, T. G. (1996) · The Journal of Physiology · doi:10.1113/jphysiol.1996.sp021319 · Cited by 106
Brooks‐Kayal, A. R., Shumate, M. D., Jin, H., Lin, D. D., Rikhter, T. Y., Holloway, K. L., & Coulter, D. A. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-19-08312.1999 · Cited by 100
GABAA Receptor alpha 4 Subunit Suppression Prevents Withdrawal Properties of an Endogenous Steroid
Smith, S. S., Gong, Q. H., Hsu, F., Markowitz, R. S., ffrench-Mullen, J. M. H., & Li, X. (1998) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199809000-00019 · Cited by 100
Yang, W., Drewe, J. A., & Lan, N. C. (1995) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(95)90072-1 · Cited by 67
Saxena, N., Neelands, T. R., & Macdonald, R. L. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.2.328 · Cited by 50
Physiological Properties of GABAAReceptors From Acutely Dissociated Rat Dentate Granule Cells
Kapur, J., Haas, K. F., & Macdonald, R. L. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.81.5.2464 · Cited by 20
Research works printed but not linked: 2
- 10.1016/S0014-2999(01)01558-8 · doi:10.1016/s0014-2999(01)01558-8
- SIEGHART W., 1995, Structure and function of γ‐aminobutyric acidA receptor subtypes, Pharmacol. Rev., 47, 181
Cited by
Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors
Farrant, M., & Nusser, Z. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1625 · Cited by 2,081
Neurosteroids: endogenous regulators of the GABAA receptor
Belelli, D., & Lambert, J. J. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1703 · Cited by 1,159
Olsen, R. W., & Sieghart, W. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00505 · Cited by 1,064
GABAA receptors: Subtypes provide diversity of function and pharmacology
Olsen, R. W., & Sieghart, W. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.045 · Cited by 982
Stell, B. M., Brickley, S. G., Tang, C. Y., Farrant, M., & Mody, I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2435457100 · Cited by 797
Metadata
- Authors
- Brown, N., Kerby, J., Bonnert, T. P., Whiting, P. J., & Wafford, K. A.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2002-08
- Volume
- 136
- Issue
- 7
- Pages
- 965-974
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2061947653
- Cited by
- 603
- References
- 38
- FWCI
- 10.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.